PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,824,185 | -46.6% | 176,591 | -32.2% | 0.01% | -44.4% |
| Q2 2023 | $3,416,938 | +0.1% | 260,636 | -14.6% | 0.01% | -10.0% |
| Q1 2023 | $3,412,930 | +204.9% | 305,271 | +129.9% | 0.01% | +150.0% |
| Q4 2022 | $1,119,319 | -16.8% | 132,778 | +64.4% | 0.00% | -20.0% |
| Q3 2022 | $1,345,000 | -35.9% | 80,750 | -43.3% | 0.01% | -28.6% |
| Q2 2022 | $2,098,000 | +193.4% | 142,511 | +394.2% | 0.01% | +250.0% |
| Q1 2022 | $715,000 | -85.9% | 28,835 | -79.6% | 0.00% | -81.8% |
| Q3 2021 | $5,087,000 | +602.6% | 141,372 | +762.0% | 0.01% | +450.0% |
| Q2 2021 | $724,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |